Literature DB >> 415925

Insulin therapy in relation to circulating C-peptide levels.

W Beischer, W Kerner, S Raptis, L Keller, B Beischer, E F Pfeiffer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 415925     DOI: 10.2337/diab.27.1.s235

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  8 in total

1.  The newer insulins.

Authors:  J G Devlin; O Maguire; V Parameswaran
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

2.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

Review 3.  The expanding clinical use of C-peptide radioimmunoassay.

Authors:  M Rendell
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

4.  The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?

Authors:  I Peacock; R B Tattersall
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-30

5.  Clinical application of the 24-H urinary C-peptide excretion rate and its relationship to metabolic control in diabetics.

Authors:  R Pasquali; P Biso; G Baraldi; L Mattioli; M Capelli; F Pasqui; N Melchionda
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

6.  Residual beta cell function in insulin-dependent diabetes: evaluation by circadian determination of C-peptide immunoreactivity.

Authors:  B Canivet; M Harter; G Viot; N Balarac; B P Krebs
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

7.  Diabetic control in 102 insulin-treated out-patients.

Authors:  G Tchobroutsky; D Charitanski; Y Blouquit; L Papoz; J Soria; J Rosa
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

8.  Postprandial 2-hr C-peptide concentration as a guide for insulin treatment in patient with NIDDM.

Authors:  R S Kim; I M Yang; J W Kim; Y S Kim; K W Kim; S W Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.